Abstract: A novel bacterial strain of Bacillus thuringiensis for inhibiting insect pests is provided, wherein the Bacillus thuringiensis includes the fragments of cry1Aa, a cry1Ab, a cry1C, a cry1D and a cry1F genes.

Abstract: A novel bacterial strain of Bacillus thuringiensis for inhibiting insect pests is provided, wherein the Bacillus thuringiensis includes the gene fragments of cry1Ab, cry1Ac, cry1D, and cry1E.

Abstract: A novel bacterial strain of Bacillus thuringiensis for inhibiting insect pests is provided, wherein the Bacillus thuringiensis includes the gene fragments of cry1Ab, cry1Ac, cry1D, and cry1E.

Abstract: An isolated Bacillus amyloliquefaciens Ba-BPD1 having an Accession No. of DSM 21836 is provided. This novel strain has unique 16S ribosomal RNA sequenced as SEQ ID NO:1 and produces amylase, protease, cellulase and lipase, fibrinolytic enzyme to show their biodegradation capacities. Further, B. amyloliquefaciens Ba-BPD1 produces the antibiotic substances, such as iturin, fengycin and surfactin, and has antimicrobial capacity for inhibiting the fungal or bacterial growth. In conclusion, the novel strain of Bacillus amyloliquefaciens Ba-BPD1 and its products can be applied in agriculture, wastewater treatment, food industry and chemical industry.

Abstract: The present invention relates to use of bicistronic DNA constructs for identifying compounds that inhibits IRES-dependent translation activity of an infectious enterovirus (EV) or encephalomyocarditis virus (EMCV) without affecting CAP-dependent translation activity of a host subject. The compounds thus identified are useful in preparation of a medicament for treating EV or EMCV infection.

Abstract: A novel bacterial strain of Bacillus thuringiensis for inhibiting insect pests is provided, wherein the Bacillus thuringiensis includes the fragments of cry1Aa, a cry1Ab, a cry1C, a cry1D and a cry1F genes.

Abstract: The present invention relates to use of bicistronic DNA constructs for identifying compounds that inhibits IRES-dependent translation activity of an infectious enterovirus (EV) or encephalomyocarditis virus (EMCV) without affecting CAP-dependent translation activity of a host subject. The compounds thus identified are useful in preparation of a medicament for treating EV or EMCV infection.

Abstract: The present invention relates to use of bicistronic DNA constructs for identifying compounds that inhibits IRES-dependent translation activity of an infectious enterovirus (EV) or encephalomyocarditis virus (EMCV) without affecting CAP-dependent translation activity of a host subject. The compounds thus identified are useful in preparation of a medicament for treating EV or EMCV infection.

Abstract: The present invention relates to use of bicistronic DNA constructs for identifying compounds that inhibits IRES-dependent translation activity of an infectious enterovirus (EV) or encephalomyocarditis virus (EMCV) without affecting CAP-dependent translation activity of a host subject. The compounds thus identified are useful in preparation of a medicament for treating EV or EMCV infection.

Abstract: An insect larva aerosol infection method for producing recombinant proteins and baculovirus bio-insecticides is disclosed. A liquid spray of budded form baculoviruses are employed to infect insect larvae in order to reduce the manpower for manual injections and the energy wasted in feeding infection technologies. The invention may be applied to the production of recombinant proteins and baculoviruses as the production platform for bio-insecticides.

Abstract: The present invention relates to use of bicistronic DNA constructs for identifying compounds that inhibits IRES-dependent translation activity of an infectious enterovirus (EV) or encephalomyocarditis virus (EMCV) without affecting CAP-dependent translation activity of a host subject. The compounds thus identified are useful in preparation of a medicament for treating EV or EMCV infection.

Abstract: The present invention provides a method of tracking the presence of genetic modified baculoviruses (GMBVs) in pest insects, comprising infecting the pest insects with GMBVs, which are engineered to express tracer proteins, i.e., coral red fluorescence proteins. The color of the expressed coral red fluorescence proteins are red or pink and are bright enough to be seen by naked eyes under direct sunlight, thereby enabling the pest insects that are infected with GMBVs to be easily distinguished from the uninfected ones.

Abstract: This specification discloses an insect larva aerosol infection method for producing recombinant proteins and baculovirus bio-insecticides. Liquid spray of budding form baculoviruses are employed to infect insect larvae to reduce the manpower for manual injections and energy waste in feeding infection technologies. The invention can be applied to the production of recombinant proteins and baculoviruses as the production platform for bio-insecticides.

Abstract: A solid fermentation production method for fungus spores necessitating high nutrient, including steps of mixing grain with yeast, sugar honey, fish milk and water at a certain ratio, steaming/cooking and stirring the mixture to make the grain have high nutrient content, transplanting fungus spores onto the grain after killing bacteria and solidly fermenting the fungus spores to mass-reproduce spores.

Abstract: The present invention provides for the use of a sweet potato sporamin gene in insect-resistance, in which the gene is inserted into an appropriate vector, then the gene is transformed into plants to enhance the plant's insect resistance, for the purpose of controlling pests.

Abstract: A particulate controlled-release pesticide composition having a pesticide encapsulated in a polymer matrix of starch-borax-urea and method of preparation and use thereof is provided. The release rates and release duration of the pesticide compositions are controllable by adjusting the urea content in the compositions. The pesticide composition is preparable by admixing starch, pesticide, urea and water together to form a mixture and agitating the same at a temperature sufficient to gelatinize the mixture and to disperse the mixture. Borax is then added to the mixture in an amount effective to convert the mixture into a rubbery mass. The rubbery mass is then comminuted into small particles, in the presence of added starch, and dried.

Abstract: A biocidal formulation with improved resistance to ultraviolet rays comprising: (a) an appropriate biocide which is Bacillus thuringiensis; (b) an anti-ultraviolet agent selected from the group consisting of 2-(2-H-benzotriazole-2-yl)-phenol and their derivatives represented by the following formula: ##STR1## wherein R.sub.1 and R.sub.2 are independently selected from the group consisting of alkyl, aryl, and alkylaryl groups; (c) pre-gelatinized starch; and (d) natural starch, the biocide, the anti-ultraviolet agent, the pre-gelatinized starch and the natural starch are mixed then baked at 60.degree.-90.degree. C. to form the biocidal formulation.

Abstract: Biocidal formulations prepared by: (a) blending predetermined amounts of pre-gelatinized starch, natural starch, biocide such as Bacillus thuringiensis and water to form a mass; (b) drying said mass by heating prepared by with a hot roller at temperatures between 50.degree. and 100.degree. C., preferably between 60.degree. and 90.degree. C., to form a dried mass; and (c) crushing the dried mass to form the final product having the shape of flakes with a diameter preferably less than about 900.mu.. With the method disclosed in the present invention, the process time can be reduced from 24 hours in the prior art to no more than 30 minutes, preferably about 3 to 15 minutes. The present invention represents substantial economic benefits as well as reductions of potential health risks as a result of the reduced contact by operators with biocides during the preparation process.